Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception

HIV Medicine

Volumn 9, Issue 10, 2008, Pages 897-900

  Le Moing, V ^a,b,i,j   Taieb A ^c,d   Longuet, P ^e,f   Lewden, C ^c,d,j   Delcey, V ^g   Thiebaut Drobacheff, M C ^h   Chene G ^c,d,j   Leport, C ^e,f,j   Raffi, F ^j,j   Salamon, R ^j   Moatti, J P ^j   Pierret, J ^j   Spire, B ^j   Brun Vezinet F ^j   Fleury, H ^j   Masquelier, B ^j   Peytavin, G ^j   Garraffo, R ^j   Costagliola, D ^j   Dellamonica, P ^j,j   Katlama, C ^j   Meyer, L ^j   Morin, M ^j   Salmon, D ^j,j   Sobel, A ^j,j   Cuzin, L ^j   Dupon, M ^j,j   Duval, X ^j   Marchou, B ^j,j   May, T ^j,j   Morlat, P ^j,j   Rabaud, C ^j   Waldner Combernoux, A ^j   Collin, F ^j   Bursachi, P ^j   Delfraissy, J F ^j   Dormon, J ^j   Garre M ^j,j   Schmit, J L ^j   Chennebault, J M ^j   Faller, J P ^j   Dupond, J L ^j   Estavoyer, J M ^j   Humbert, P ^j   Krivitzky, A ^j   Longy Boursier, ^j   Ragnaud, J M ^j   Granier, P ^j   Verdon, R ^j   Domart, Y ^j   Devidas, A ^j   Portier, H ^j   Perronne, C ^j   Lagarde, P ^j   Ceccaldi, J ^j   Peyramond, D ^j   Allard, C ^j   Reynes, J ^j   Cassuto, J P ^j   Arsac, P ^j   Bouvet, E ^j   Bricaire, F ^j   Bergmann, P ^j   Cabane, J ^j   Cessot, G ^j   Girard, P M ^j   Guillevin, L ^j   Herson, S ^j   Meyohas, M C ^j   Molina, J M ^j   Pialoux, G ^j   Becq Giraudon, B ^j   Jaussaud, R ^j   Michelet, C ^j   Lucht, F ^j   Debord, T ^j   Lang, J M ^j   De Jaureguiberry, J P ^j   Besnier, J M ^j   Alfaro, C ^j   Alkaied, F ^j   Boucherit, S ^j   Bouhnik, A D ^j   Brunet Francois C ^j   Carrieri, M P ^j   Courcoul, M ^j   Couturier, F ^j   Ecobichon, J L ^j   Francois M ^j   Iordache, L ^j   Journot, V ^j   Kurkdji, P ^j   Legrand, J P ^j   Lootvoet, E ^j   Pereira, E ^j   Preau M ^j   Protopopescu, C ^j   Roy, C ^j   Surzyn, J ^j   Taieb, A ^j   Tourteau, F ^j   Villes, V ^j   Zouari, H ^j   more..

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f BICHAT HOSPITAL   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h HÔPITAL SAINT JACQUES   (France)

ⁱ GUI DE CHAULIAC HOSPITAL   (France)

^j NONE

more..

Author keywords

Antiretroviral therapy; CD4 lymphocyte count; Highly active; HIV infection; Pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONCEPTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; VIRUS LOAD;

EID: 55749102686     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00641.x     Document Type: Article

References (12)

1. The European Collaborative Study and the Swiss HIV Pregnancy Cohort. Immunological markers in HIV-infected pregnant women. AIDS 1997; 11: 1859-1865.
2. HockéC, Morlat P, Chêne G, Dequae L, Dabis F. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Obstet Gynecol 1995; 86: 556-591.
3. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: A systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105: 827-835.
4. Saada M, Le Chenadec J, Berrebi A et al. Pregnancy and progression to AIDS: Results of two French prospective cohorts. AIDS 2000; 14: 2355-2360.
5. Martin F, Navaratne L, Khan W et al. Pregnant women with HIV infection can expect healthy survival. Three-year follow-up. J Acquir Immune Defic Syndr 2006; 43: 186-192.
6. Tai JH, Udoji MA, Barkanic G et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis 2007; 196: 1044-1052.
7. Le Moing V, Chêne G, Carrieri MP et al. Predictors of virological rebound in a cohort of HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS 2002; 16: 21-29.
8. Le Moing V, Thiebaut R, Chêne G et al. Predictors of long-term increase of CD4 cell counts in human immunodeficiency virus-infected patients initiating a protease inhibitor-containing regimen. J Infect Dis 2002; 185: 471-480.
9. Le Moing V, Thiebaut R, Chêne G et al. Long-term evolution of CD4 in patients with a plasma HIV RNA persistently <500 copies/ml while treated with antiretroviral drugs. HIV Med 2007; 8: 157-163.
10. Fiore S, Newell ML, Trabattoni D et al. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol 2006; 70: 143-150.
11. Tuomala RE, Shapiro DE, Moffenson DM et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002; 346: 1863-1870.
12. Suy A, Martinez E, Coll O et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006; 50: 59-66.